Boryung
Boryung, officially known as Boryung Pharmaceutical Co., Ltd., is a prominent player in the pharmaceutical industry, headquartered in South Korea (KR). Established in 1963, the company has made significant strides in developing innovative healthcare solutions, particularly in the fields of pharmaceuticals and biotechnology. With a strong presence in both domestic and international markets, Boryung focuses on a diverse range of therapeutic areas, including oncology, cardiology, and infectious diseases. Its core products, which include advanced biopharmaceuticals and generics, are distinguished by their high quality and efficacy. Boryung has achieved notable milestones, such as expanding its global footprint and securing partnerships with leading research institutions. This commitment to innovation and excellence has solidified its position as a trusted name in the healthcare sector, making significant contributions to improving patient outcomes worldwide.
DitchCarbon Score
How does Boryung's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Boryung's score of 25 is lower than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Boryung's reported carbon emissions
In 2023, Boryung reported total carbon emissions of approximately 27,457,000 kg CO2e, encompassing Scope 1 and 2 emissions. This figure reflects a slight decrease from 2022, where emissions were about 27,499,000 kg CO2e. Over the past few years, Boryung has demonstrated a commitment to reducing its carbon footprint, with emissions in 2021 recorded at approximately 24,857,000 kg CO2e, indicating a positive trend towards lower emissions. Despite these reductions, Boryung has not publicly disclosed specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. The company has not provided data on Scope 3 emissions, which typically encompass indirect emissions from the supply chain and product use. Boryung's emissions data highlights its ongoing efforts to manage and reduce its environmental impact, aligning with industry standards for climate accountability. The company continues to monitor its emissions and is expected to enhance its climate commitments in the future.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 3,906,000 | - | - | - |
| Scope 2 | 22,623,000 | - | - | - |
| Scope 3 | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Boryung is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
